Sort   by:  
 Page size 
UnknownSpectroscopic Characterization and Nanosafety of Ag-Modified Antibacterial Leather and Leatherette.
Not available
S-EPMC5575685 | biostudies-literature
UnknownPain REduction with bone metastases STereotactic radiotherapy (PREST): A phase III randomized multicentric trial.
Not available
S-EPMC6816218 | biostudies-literature
UnknownPalliative radiotherapy indications during the COVID-19 pandemic and in future complex logistic settings: the NORMALITY model.
Not available
S-EPMC8475365 | biostudies-literature
UnknownPrognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription.
Not available
S-EPMC9827357 | biostudies-literature
UnknownEarly High-Titer Plasma Therapy to Prevent Severe Covid-19 in Older Adults.
Not available
S-EPMC7793608 | biostudies-literature
UnknownCord blood transfusions in extremely low gestational age neonates to reduce severe retinopathy of prematurity: results of a prespecified interim analysis of the randomized BORN trial.
Not available
S-EPMC11305044 | biostudies-literature
UnknownCord red blood cell transfusions for severe retinopathy in preterm neonates in Italy: a multicenter randomized controlled trial.
Not available
S-EPMC12361995 | biostudies-literature
UnknownEffects of the dose of erythropoiesis stimulating agents on cardiovascular events, quality of life, and health-related costs in hemodialysis patients: the clinical evaluation of the dose of erythropoietins (C.E. DOSE) trial protocol.
Not available
S-EPMC2903576 | biostudies-literature
UnknownEfficacy of n-3 polyunsaturated fatty acids and feasibility of optimizing preventive strategies in patients at high cardiovascular risk: rationale, design and baseline characteristics of the Rischio and Prevenzione study, a large randomised trial in general practice.
Not available
S-EPMC2909229 | biostudies-literature
UnknownLong-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial.
Not available
S-EPMC3596060 | biostudies-literature
Sort   by:  
 Page size